WHO ICTRP trial
We will see the effect of Nimba and lodhra Araka Aschyotana in vataja abhish…
CTRI/2025/08/092766 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2025/08/092766 |
|---|---|
| Public title | We will see the effect of Nimba and lodhra Araka Aschyotana in vataja abhish shyada We will also see the effect of olapetedine eye drop in vataja abhishyanda with special reference to allergic conjunctivitis |
| Scientific title | A Randomized Controlled Trial of Nimba-Lodhra Arka(eye drop)Aschyotana in Vataja Abhishyanda with special reference to Allergic conjunctivitis. - nil |
| Primary sponsor | Dr Muskan Rahim Shaikh |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2/ Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: H102- Other acute conjunctivitis |
| Registration date | Nov 8, 2025 |
| Target size | 80 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: